Journal of Bone and Joint Infection (Oct 2024)

Efficacy of rezafungin in a case of <i>Candida</i> spondylodiskitis

  • M. Lahouati,
  • M. Lahouati,
  • C. Tinévez,
  • C. Tinévez,
  • F. Gabriel,
  • F. Xuereb,
  • F. Xuereb,
  • M. Lefranc,
  • F.-A. Dauchy,
  • F.-A. Dauchy

DOI
https://doi.org/10.5194/jbji-9-213-2024
Journal volume & issue
Vol. 9
pp. 213 – 215

Abstract

Read online

Rezafungin, which only requires weekly administration, is a potential candidate for difficult-to-treat infections that require long-term antimicrobial treatment, such as bone and joint infections. We report the first case of Candida glabrata spondylodiskitis successfully treated with 3 weeks of caspofungin followed by 10 weeks of rezafungin.